• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD.

作者信息

Mihai Carina, Dobrota Rucsandra, Schröder Maria, Garaiman Alexandru, Jordan Suzana, Becker Mike Oliver, Maurer Britta, Distler Oliver

机构信息

Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland.

Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland

出版信息

Ann Rheum Dis. 2020 May;79(5):668-669. doi: 10.1136/annrheumdis-2020-217442. Epub 2020 Apr 2.

DOI:10.1136/annrheumdis-2020-217442
PMID:32241792
Abstract
摘要

相似文献

1
COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD.一名接受托珠单抗治疗系统性硬化症相关间质性肺病的系统性硬化症患者感染了新冠病毒。
Ann Rheum Dis. 2020 May;79(5):668-669. doi: 10.1136/annrheumdis-2020-217442. Epub 2020 Apr 2.
2
Tocilizumab for Hemophagocytic Syndrome in a Kidney Transplant Recipient With COVID-19.托珠单抗用于一名合并 COVID-19 的肾移植受者的噬血细胞综合征
Ann Intern Med. 2020 Sep 15;173(6):501-503. doi: 10.7326/L20-0419. Epub 2020 May 18.
3
'Toxic erythema' and eosinophilia associated with tocilizumab therapy in a COVID-19 patient.一名新冠患者中与托珠单抗治疗相关的“中毒性红斑”和嗜酸性粒细胞增多症
J Eur Acad Dermatol Venereol. 2020 Aug;34(8):e368-e370. doi: 10.1111/jdv.16620. Epub 2020 Jun 8.
4
Hyper-inflammatory Syndrome in a Child With COVID-19 Treated Successfully With Intravenous Immunoglobulin and Tocilizumab.一名感染新冠病毒的儿童出现高炎症综合征，经静脉注射免疫球蛋白和托珠单抗成功治愈。
Indian Pediatr. 2020 Jul 15;57(7):681-683. doi: 10.1007/s13312-020-1901-z. Epub 2020 May 10.
5
Rapid resolution of cytokine release syndrome and favorable clinical course of severe COVID-19 in a kidney transplant recipient treated with tocilizumab.在用托珠单抗治疗的肾移植受者中，细胞因子释放综合征迅速缓解，重症 COVID-19 临床病程良好。
Kidney Int. 2020 Aug;98(2):508-509. doi: 10.1016/j.kint.2020.05.022. Epub 2020 Jun 4.
6
Rapid and severe Covid-19 pneumonia with severe acute chest syndrome in a sickle cell patient successfully treated with tocilizumab.一名镰状细胞病患者出现快速进展且严重的新冠病毒肺炎并伴有严重急性胸部综合征，使用托珠单抗成功治疗。
Am J Hematol. 2020 Jul;95(7):876-878. doi: 10.1002/ajh.25833. Epub 2020 May 12.
7
First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab.首例多发性骨髓瘤合并 COVID-19 患者经托珠单抗治疗后成功缓解。
Blood Adv. 2020 Apr 14;4(7):1307-1310. doi: 10.1182/bloodadvances.2020001907.
8
COVID-19 in a Patient With Rheumatoid Arthritis During Tocilizumab Treatment.托珠单抗治疗期间类风湿关节炎患者的COVID-19感染
J Clin Rheumatol. 2020 Sep;26(6):240-241. doi: 10.1097/RHU.0000000000001576.
9
Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report.托珠单抗，一种抗白细胞介素-6受体抗体，用于治疗新型冠状病毒肺炎相关呼吸衰竭：一例病例报告。
Ann Oncol. 2020 Jul;31(7):961-964. doi: 10.1016/j.annonc.2020.03.300. Epub 2020 Apr 2.
10
Improvement of SARS-CoV-2 symptoms following Guselkumab injection in a psoriatic patient.一名银屑病患者注射古塞库单抗后新冠病毒症状改善。
J Eur Acad Dermatol Venereol. 2020 Aug;34(8):e363-e364. doi: 10.1111/jdv.16590. Epub 2020 Jun 4.

引用本文的文献

1
The impact of COVID-19 on clinical course and treatment among patients with juvenile systemic sclerosis.新型冠状病毒肺炎对青少年系统性硬化症患者临床病程及治疗的影响。
Arch Rheumatol. 2022 Nov 4;38(2):267-273. doi: 10.46497/ArchRheumatol.2023.9636. eCollection 2023 Jun.
2
Systemic sclerosis in the time of COVID-19.新冠疫情时期的系统性硬化症
Lancet Rheumatol. 2022 Aug;4(8):e566-e575. doi: 10.1016/S2665-9913(22)00130-8. Epub 2022 Jul 21.
3
Anti-Rheumatic Drugs May Ameliorate the Clinical Course and Outcome of COVID-19 In Rheumatoid Arthritis Patients.
抗风湿药物可能改善类风湿关节炎患者COVID-19的临床病程及结局。
Mediterr J Rheumatol. 2022 Mar 31;33(1):68-74. doi: 10.31138/mjr.33.1.68. eCollection 2022 Mar.
4
COVID-19 and systemic sclerosis: Rising to the challenge of a pandemic.2019冠状病毒病与系统性硬化症：应对大流行的挑战
J Scleroderma Relat Disord. 2021 Feb;6(1):58-65. doi: 10.1177/2397198320963393. Epub 2020 Oct 18.
5
Immuno-oncologic care during COVID-19: Challenges and opportunities for improving clinical care and investigation.2019冠状病毒病期间的免疫肿瘤治疗：改善临床护理与研究的挑战和机遇
J Cancer Biol. 2021;2(3):75-82. doi: 10.46439/cancerbiology.2.029.
6
Insight into COVID-19's epidemiology, pathology, and treatment.深入了解新型冠状病毒肺炎的流行病学、病理学及治疗方法。
Heliyon. 2022 Jan;8(1):e08799. doi: 10.1016/j.heliyon.2022.e08799. Epub 2022 Jan 19.
7
COVID-19 and Autoimmune/Autoinflammatory Rheumatic Disease Patients: Lessons Learned and Questions Anticipating Answers.2019冠状病毒病与自身免疫性/自身炎症性风湿性疾病患者：经验教训与有待解答的问题
Mediterr J Rheumatol. 2021 Sep 6;32(3):188-191. doi: 10.31138/mjr.32.3.188. eCollection 2021 Sep.
8
Effects of statins and steroids on coronary artery disease and stroke in patients with interstitial lung disease and pulmonary fibrosis: A general population study.他汀类药物和类固醇对间质性肺疾病和肺纤维化患者的冠心病和中风的影响：一项普通人群研究。
PLoS One. 2021 Oct 27;16(10):e0259153. doi: 10.1371/journal.pone.0259153. eCollection 2021.
9
Humoral Response to SARS-CoV-2 Vaccine of a Patient Receiving Methotrexate Treatment and Implications for the Need of Monitoring.接受甲氨蝶呤治疗患者对SARS-CoV-2疫苗的体液反应及监测必要性的影响
Vaccines (Basel). 2021 Oct 9;9(10):1151. doi: 10.3390/vaccines9101151.
10
COVID-19 Immunobiology: Lessons Learned, New Questions Arise.COVID-19 免疫生物学：经验教训，新问题浮现。
Front Immunol. 2021 Aug 26;12:719023. doi: 10.3389/fimmu.2021.719023. eCollection 2021.